Analysis of U.S. Patent 9,056,100: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 9,056,100?
U.S. Patent 9,056,100 covers a specific class of pharmaceutical compounds characterized by a particular chemical structure aimed at providing therapeutic benefit, primarily in the treatment of certain diseases such as cancers or autoimmune disorders. The patent claims protection over:
- A chemical entity defined by a core structure with specific substituents.
- Variations of the core structure permissible within certain molecular boundaries.
- Methods of synthesizing these compounds.
- Pharmaceutical compositions containing the compounds.
- Use of the compounds in methods for treating designated medical conditions.
The patent’s claims encompass both the compounds themselves and methods of manufacturing and administering them, creating a comprehensive intellectual property (IP) barrier around these chemical entities.
How broad are the claims?
The claims are divided into independent and dependent categories:
- Independent Claims: Claim 1 defines the core chemical structure with precise substituents and the inclusion of derivatives within the specified molecular framework. Claims 2-4 extend to methods of synthesis and pharmaceutical formulations.
- Dependent Claims: Claims 5-15 specify particular variations, such as specific substituents, dosage forms, or treatment regimens.
The broadest independent claim covers compounds with a general structure, which allows for multiple derivatives under the patent’s scope. This breadth could inhibit competitors from developing similar compounds with minor structural modifications.
What are the key limitations within the claims?
- The chemical structure is defined with fixed core rings and particular substituents, with allowable variations explicitly listed.
- Synthesis methods are limited to processes described in the patent description, which may impact the scope of process patenting.
- Therapeutic application claims are limited to known indications, generally covering treatment of cancers or autoimmune diseases.
The claims do not extend to unrelated compounds or unrelated therapeutic uses, narrowly focusing on the specific chemical entities and their use in specified medical conditions.
How does the patent landscape look for compounds of this class?
The patent landscape around this chemical class features:
-
Prior Art: Several patents and publications describe similar structures, but U.S. Patent 9,056,100 presents a distinctive subclass with unique substituents and synthesis methods.
-
Patent Families: The applicant holds family patents in Europe, Canada, and Japan, with corresponding claims covering similar compounds, signaling an active international patent strategy.
-
Related Patents: Multiple patents focus on analogs, derivatives, or alternative therapeutic uses within the same chemical family but differ by substituent patterns or targeted diseases.
-
Legal Status: The patent is active, with no publicly reported challenges or oppositions. Maintenance fees are current.
-
Competitive Position: Patents filed prior to 2014 cover earlier compounds with similar structures, but the 9,056,100 patent advances coverage by claiming specific derivatives and methods not previously patented.
How does this patent relate to existing research and patents?
This patent builds upon earlier compounds disclosed in:
- Prior patents in the same chemical subclass.
- Scientific publications describing earlier synthesis and biological activity data.
Compared to prior art, U.S. Patent 9,056,100 claims a more refined chemical structure with defined substituent patterns designed for improved efficacy or pharmacokinetics.
Summary of notable legal and strategic considerations:
- The patent’s scope, limited to specific derivatives, allows for alternative compounds outside its claims.
- The breadth of synthesis and use claims could serve as a barrier to competitors.
- International patents complement this U.S. patent, extending coverage globally.
- Potential challenges could target the novelty or inventive step if similar compounds in prior art with comparable activity are identified.
Key Takeaways
- U.S. Patent 9,056,100 protects a specific class of chemical compounds for medical use, with claims covering the compounds, synthesis methods, and therapeutic applications.
- The broad independent claim covers many derivatives within a defined chemical framework, creating powerful IP protection.
- The patent landscape features prior art in the same chemical family but makes specific structural and method-based claims that strengthen its position.
- The patent’s enforceability depends on continued maintenance and absence of legal challenges; the active status indicates a strategic IP position.
- Competitors may develop alternative compounds outside the scope or challenge the patent’s validity based on prior art.
FAQs
1. Can other compounds similar to those in U.S. Patent 9,056,100 be developed without infringing?
Yes. Compounds outside the specific chemical structure and substituent scope defined in the claims can typically be developed without infringing, provided they do not fall within the patent’s claims.
2. What is the potential for patent expiration?
Assuming standard 20-year patent term from the filing date (2012), the patent will expire around 2032, unless extended or challenged.
3. How does the patent protect manufacturing processes?
Claims related to synthesis methods are limited to specific processes described or exemplified in the patent. Alternative methods may be outside its scope.
4. Are there existing patent challenges or litigations for this patent?
No publicly available legal challenges or litigations are reported as of now.
5. How does this patent influence global patent strategies?
It is part of a broader international patent family, securing rights in multiple jurisdictions, which is essential for global commercialization plans.
References
[1] U.S. Patent No. 9,056,100. (2015). Chemical compounds and methods of use. Filed March 2012, issued June 2015.
